Mavacamten in Obstructive Hypertrophic Cardiomyopathy and C282Y Homozygous Hereditary Hemochromatosis: A First-in-Human Report.
Saved in:
| Title: | Mavacamten in Obstructive Hypertrophic Cardiomyopathy and C282Y Homozygous Hereditary Hemochromatosis: A First-in-Human Report. |
|---|---|
| Authors: | Sam R; Division of Cardiology, Endeavor Health, Glenview, Illinois, USA; Division of Cardiology, University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA. Electronic address: riyasam@gmail.com., Ananthaneni A; Division of Hematology/Oncology, Louisiana State University Health Sciences, Shreveport, Louisiana, USA., Planek MI; Division of Cardiology, Endeavor Health, Glenview, Illinois, USA; Division of Cardiology, University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA., Kogan A; Division of Cardiology, Endeavor Health, Glenview, Illinois, USA., Gordon R; Division of Cardiology, Endeavor Health, Glenview, Illinois, USA; Division of Cardiology, University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA. |
| Source: | JACC. Case reports [JACC Case Rep] 2026 May 06; Vol. 31 (18), pp. 107736. Date of Electronic Publication: 2026 Mar 31. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: Netherlands NLM ID: 101757292 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-0849 (Electronic) Linking ISSN: 26660849 NLM ISO Abbreviation: JACC Case Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
